These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36154586)

  • 1. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
    Dai X; Chen K; Xie Y
    Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
    Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
    Environ Toxicol; 2023 Jun; 38(6):1455-1465. PubMed ID: 36988233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.
    Liu N; Zhang C; Zhang L
    Mol Biotechnol; 2024 Aug; 66(8):1883-1893. PubMed ID: 37477820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
    Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
    Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
    Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
    FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
    Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
    Genomics; 2023 Jan; ():110566. PubMed ID: 36690262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
    Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q
    Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
    Zheng H; Cao Z; Lv Y; Cai X
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WTAP-mediated N6-methyladenosine modification promotes the inflammation, mitochondrial damage and ferroptosis of kidney tubular epithelial cells in acute kidney injury by regulating LMNB1 expression and activating NF-κB and JAK2/STAT3 pathways.
    Huang F; Wang Y; Lv X; Huang C
    J Bioenerg Biomembr; 2024 Jun; 56(3):285-296. PubMed ID: 38517565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression.
    He RZ; Jiang J; Hu X; Lei M; Li J; Luo W; Duan L; Hu Z; Mo YY; Luo DX; Peng WX
    Cancer Cell Int; 2021 Nov; 21(1):616. PubMed ID: 34809621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8.
    Zhou L; Zhong Y; Wang F; Guo Y; Mao R; Xie H; Zhang Y; Li J
    Int J Biol Sci; 2024; 20(5):1763-1777. PubMed ID: 38481803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
    Zhang Z; Mei Y; Hou M
    Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine.
    Huang L; Shao J; Xu X; Hong W; Yu W; Zheng S; Ge X
    Cell Adh Migr; 2023 Dec; 17(1):1-13. PubMed ID: 36849408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.